Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra).
Koné-Paut
I
I
Retornaz
K
K
Garnier
J M
JM
Bader-Meunier
B
B
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects*; D007898:Leishmaniasis, Visceral / Q000276:immunology*
D000893:Anti-Inflammatory Agents; D053590:Interleukin 1 Receptor Antagonist Protein